Investigation launched into certain nitisinone capsules from Sweden

Saturday, September 22, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

OTTAWA, Sept. 21, 2018 /CNW/ - The Canada Border Services Agency (CBSA) announced today that it is launching an investigation into whether or not certain

nitisinone capsules originating in or exported from Sweden are being sold at unfair prices in Canada.

The investigation is the result of a complaint filed by Laboratoires KABS

Inc. and its affiliate MendeliKABS Inc. which are both located in Saint-Hubert, Quebec. The complainant (comprised of both companies) alleges that the Canadian industry is facing declines in production, lost sales, reduced profitability, negative returns on investments, underutilization of production capacity and negative effects on growth. The initiation of this investigation does not prevent these goods from being imported into Canada and being made available to users.

Currently, there are 101 special import measures in force, covering a wide variety of products, from steel to refined sugar. These measures have directly helped to protect the Canadian economy and jobs in Canada.

Quick Facts

  • The subject goods are nitisinone capsules supplied in certain dosages. Nitisinone capsules are orally administered drugs used in the treatment of hereditary tyrosinemia type 1 (HT?1). For more product information, please refer to the CBSA's website.
  • This is the beginning of an investigation process in which the CBSA and the Canadian International Trade Tribunal (CITT) both play a role. The CITT will begin a preliminary inquiry to determine whether the evidence discloses a reasonable indication that imports are harming Canadian producers and will issue a decision by November 20, 2018.
  • Concurrently, the CBSA will investigate whether the imports are being sold in Canada at unfair prices, and will make a preliminary decision by December 20, 2018. Should the CBSA's preliminary findings indicate that exports from Sweden are being sold at unfair prices, the investigation will be continued for the purposes of making a final decision by March 20, 2019.
  • A copy of the Statement of Reasons, which provides more details about the investigation, will be available on the CBSA's website at www.cbsa.gc.ca/sima-lmsi within 15 days.

Associated Links

Special Import Measures Act (SIMA) Investigative Process and Timeframes Overview of Canada's Anti-Dumping and Countervailing Investigative ProcessesCanada Border Services Agency, Anti-dumping and CountervailingCanadian International Trade Tribunal

Media Relations

Follow us on Twitter (@CanBorder), join us on Facebook or visit our YouTube channel.

 

SOURCE Canada Border Services Agency



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store